Pressor effect of metoclopramide in phaeochromocytoma
Year: 1996
Type: article
Study design: Case Report
Abstract: Panitumumab is a new humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb) approved for the treatment of advanced colorectal cancer. There is an increase in the use of this drug due to a good response rate and possible secondary resection in advance colorectal cancer. Here we present 18F-FDG PET/CT imaging findings of cardiac arrhythmia in a patient receiving Panitumumab for the treatment of metastatic infiltrating rectal adenocarcinoma. Cardiotoxicity is a known adverse effect associated with Panitumumab. By far to our knowledge, no documented imaging findings for the same are available in the literature.
Source: Postgraduate Medical Journal
Authors: S Freestone, J Duffield, M R Lee
Institution: Edinburgh Royal Infirmary
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2078589485